The Fourth International Symposium on Immunotherapy
Royal Society
6-9 Carlton House Terrace, St James
London, United Kingdom
The Fourth International Symposium on Immunotherapy

Institute for Cancer Vaccines and Immunotherapy

Royal Society

6-9 Carlton House Terrace, St James

United Kingdom

Schedule of Presentations:

Friday, May 24, 2019
09:00:00 Registration
09:30:00 Welcome
09:35:00 Introduction Angus Dalgleish
09:40:00 CAR T cells Now and Then – SITC Sponsored Carl June
10:10:00 TIL – the gateway to adoptive cell therapy for solid tumours Robert Hawkins
10:35:00 T4 CAR T-cell immunotherapy of refractory head and neck cancer John Maher
11:00:00 TEA
11:25:00 A natural system for discriminating normality from malignancy Adrian C. Hayday
11:50:00 Proffered Paper -Adoptive immunotherapy of cancer: priming through DNA demethylated T helper cells Alexei Kirkin
12:00:00 Proffered Paper – Inactivation of PDCD1 gene in melanoma-specific CD8+ T lymphocytes
12:10:00 Proffered Paper – Anti-hPSMA CAR engineered NK-92 cells: An Off-The-Shelf cellular therapeutic for targeted elimination of prostate cancer cells Gaia Zuccolotto
12:20:00 Poster Discussion time
12:30:00 Lunch & poster viewing
13:20:00 The neoantigen landscape in cancer and response to immunotherapy
13:50:00 Small molecule modulators of antigen presentation Raj Chopra
14:20:00 Proffered Paper – APOBEC3B-mediated Mutation Induces Heteroclitic Neoepitopes for Cancer Immunotherapy
14:40:00 Reversing check point inhibition resistance Samir Khleif
15:10:00 Sensitisation of the tumour microenvironment to immune checkpoint blockade
15:30:00 TEA
16:00:00 Targeting myeloid-derived suppressor cells in melanoma by low-dose chemotherapy Viktor Umansky
16:20:00 Proffered Paper – Negative impact of antibiotic administration prior to commencement of immunotherapy across multiple tumour sites Sarah Howlett
16:40:00 Impact of tumor inherent interferons on immune reactivity and personalized therapy in triple negative breast cancer David Brockwell
17:00:00 Presentation of current data on reversing check point resistance followed by panel discussions Angus Dalgleish
17:30:00 Networking Reception and Poster Viewing at the Royal Society
Saturday, May 25, 2019
06:00:00 New Presentation
06:00:00 New Presentation
06:00:00 New Presentation
06:00:00 New Presentation
06:00:00 New Presentation
06:00:00 New Presentation
09:00:00 Repurposed Drugs and Onco-Immunology
09:15:00 Use of Cannabinoids to enhance response to chemotherapy Marco Falasca
09:40:00 Investigating the role of Cannabinoids in Cancer
10:00:00 Novel potential therapeutic uses of certain plant and synthetic cannabinoids revealed by their pharmacological properties Roger Pertwee
10:30:00 Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol
10:40:00 TEA
11:00:00 Presentation of current data on cannabinoids in cancer followed by panel discussions Angus Dalgleish
11:25:00 Immune phenotyping from measurements of the circulating proteome
11:40:00 Neoantigens and cryptic peptides: novel concepts for immunotherapy of malignant melanoma Bastian Schilling
12:00:00 Modulation of apoptosis and transcriptional activity in tumor-educated, immunosuppressive monocytes Vincenzo Bronte
12:20:00 Stress induced post translational modifications to self peptides are effective targets for cancer vaccines
12:35:00 Lunch and poster viewing
13:30:00 New therapeutic targets: Tumor innervation Michael Shurin
14:00:00 Cancer Immunotherapy in Evolution: Vaccination, Co-stimulation and Checkpoint Blockade – SITC Sponsored Bernard A. Fox
14:30:00 Proffered Paper – Can we learn lessons about immune control from transmissible tumours? Robin Weiss
14:45:00 Activation of innate and adaptive immunity to induce an in situ vaccine Paul M. Sondel
15:35:00 Proffered Paper – HLA-G as a powerful immune checkpoint and tumor specific antigen for cancer immunotherapy
15:50:00 Holbrook Kohrt Memorial Lecture – Normal and Neoplastic Stem Cells Irving L Weissman
16:35:00 Poster Prize Presentation
16:40:00 Collaboration session Angus Dalgleish
19:00:00 Royal Automobile Club (RAC). Invitation only.
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.